Sort
30,917 grants matching “tumor microenvironment”
The role of chronic stress in regulation of mutant p53 and tumorigenesis
$363,306Wenwei Hu · Rbhs -Cancer Institute Of New Jersey · R01 · FY2020 · CA
Targeting ribosome biogenesis and desmoplastic tumor microenvironment for the treatment of advanced pancreatic cancer
$363,250Bilal Bin Hafeez · University Of Texas Rio Grande Valley · SC1 · FY2023 · GM
Targeting ribosome biogenesis and desmoplastic tumor microenvironment for the treatment of advanced pancreatic cancer
$363,250Bilal Bin Hafeez · University Of Texas Rio Grande Valley · SC1 · FY2024 · GM
Targeting ribosome biogenesis and desmoplastic tumor microenvironment for the treatment of advanced pancreatic cancer
$363,250Bilal Bin Hafeez · University Of Texas Rio Grande Valley · SC1 · FY2022 · GM
Targeting ribosome biogenesis and desmoplastic tumor microenvironment for the treatment of advanced pancreatic cancer
$363,250Bilal Bin Hafeez · University Of Texas Rio Grande Valley · SC1 · FY2021 · GM
Role of YAP in Treg Function and YAP Targeting for Cancer Immunotherapy
$363,204Drew M. Pardoll · Johns Hopkins University · R01 · FY2019 · CA
The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer
$363,165Don Lynn Gibbons · University Of Tx Md Anderson Can Ctr · R37 · FY2023 · CA
DELINEATING THE EVOLUTION AND ECOLOGY OF CHEMORESISTANCE IN BREAST CANCER WITH SINGLE CELL GENOMICS
$363,164Nicholas Navin · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Dissecting the source and mechanisms of IL-17-mediated modulation of pancreatic tumorigenesis
$363,164Florencia McAllister · University Of Tx Md Anderson Can Ctr · R37 · FY2023 · CA
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
$363,164Juan Fueyo · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Role of SAP30 in hypoxia inducible factor activation and breast cancer progression
$363,164Weibo Luo · Ut Southwestern Medical Center · R01 · FY2023 · CA
DELINEATING THE EVOLUTION AND ECOLOGY OF CHEMORESISTANCE IN BREAST CANCER WITH SINGLE CELL GENOMICS
$363,164Nicholas Navin · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
$363,164Juan Fueyo · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Understanding and harnessing immune-modulatory effects of covalent KRASG12C inhibitors in KRASG12C-mutant non-small cell lung cancer
$363,164Ferdinandos Skoulidis · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Transcriptomic mechanisms underlying the immune modulating function and therapeutic efficacy of PARP inhibitors
$363,164Timothy Anthony Yap · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Paradoxical roles of tumor lymphangiogenesis on tumor immunity and implications for immunotherapy - Resubmission 01
$363,164Melody A Swartz · University Of Chicago · R01 · FY2022 · CA
Toward understanding the role of altered glycosylation in cancer
$363,139Stacy Alyse Malaker · Yale University · R35 · FY2022 · GM
The role of miRNA15a and 16-1 in Multiple Myeloma
$363,125Irene M. Ghobrial · Dana-Farber Cancer Inst · R01 · FY2012 · CA
The role of miRNA15a and 16-1 in Multiple Myeloma
$363,125Irene M. Ghobrial · Dana-Farber Cancer Inst · R01 · FY2015 · CA
The role of miRNA15a and 16-1 in Multiple Myeloma
$363,125Irene M. Ghobrial · Dana-Farber Cancer Inst · R01 · FY2011 · CA
Reprogramming of the stromal microenvironment in melanoma progression and therapeutic escape
$363,124Yuhang Zhang · University Of Cincinnati · R01 · FY2025 · CA
FOXD3 up-regulation and ERBB3 signaling as an adaptive response to BRAF inhibitors in melanoma
$363,090Andrew E Aplin · Thomas Jefferson University · R01 · FY2022 · CA
Targeted therapies in cutaneous melanoma
$363,090Andrew E Aplin · Thomas Jefferson University · R01 · FY2023 · CA
Function of Membrane Type Matrix Metalloproteinase
$363,090Stephen Weiss · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Combinatorial Targeting of Epigenomic and Microenvironmental Pathways to Suppress MAPK Inhibitor Resistance in Melanoma
$363,090Roger S Lo · University Of California Los Angeles · R01 · FY2022 · CA